Operating Expenses
Operating Lease Cost
Vertex Pharmaceuticals Operating Lease Cost remained flat by 0.0% to $48.68M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 87.4%, from $25.98M to $48.68M. Over 2 years (FY 2023 to FY 2025), Operating Lease Cost shows an upward trend with a 101.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Increasing costs signal higher recurring operational overhead related to leased assets.
Detailed definition
The portion of total lease expense specifically attributable to operating leases, recognized on a straight-line basis ov...
Peer comparison
Standard metric for comparing rental and leasing overhead across retail, manufacturing, and logistics sectors.
Metric ID:
cat_operating_lease_costHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $47.80M | $103.90M | $194.70M |
| YoY Change | — | +117.4% | +87.4% |
Range$47.80M – $194.70M
CAGR+101.8%
Avg YoY Growth+102.4%
Median YoY Growth+102.4%
Current Streak2+ years growth
Operating Lease Cost at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's operating lease cost?
- Vertex Pharmaceuticals (VRTX) reported operating lease cost of $48.68M in Q4 2025.
- How has Vertex Pharmaceuticals's operating lease cost changed year-over-year?
- Vertex Pharmaceuticals's operating lease cost increased by 87.4% year-over-year, from $25.98M to $48.68M.
- What is the long-term trend for Vertex Pharmaceuticals's operating lease cost?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's operating lease cost has grown at a 101.8% compound annual growth rate (CAGR), from $47.80M to $194.70M.
- What does operating lease cost mean?
- The expense recognized for operating leases.